The present disclosure relates to methods for treating acne, e.g., moderate to severe inflammatory acne, using IL-17 antagonists, e.g., secukinumab or CJM112. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab or CJM112, for treating acne patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.本發明係關於使用IL-17拮抗劑，例如塞庫金單抗(secukinumab)或CJM112治療痤瘡，例如中度至重度發炎性痤瘡的方法。本文亦揭示IL-17拮抗劑，例如諸如塞庫金單抗或CJM112之IL-17抗體，用於治療痤瘡患者的用途，以及用於該等所揭示之用途及方法中之藥劑、給藥方案、醫藥調配物、劑型及套組。
